Mark Guinan - 07 Mar 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role: Executive Vice President & CFO
Signature: /s/ William J. O'Shaughnessy, Jr., Attorney-in-Fact for Mark J. Guinan
Issuer symbol: DGX
Transactions as of: 07 Mar 2022
Net transactions value: +$1,340,577
Form type: 4
Filing time: 09 Mar 2022, 15:48:30 UTC
Previous filing: 28 Feb 2022
Next filing: 28 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DGX	Common Stock	Award	$2,703,270	+20,780	+23%	$130.09	109,456	07 Mar 2022	Direct	F1
transaction	DGX	Common Stock	Tax liability	$1,362,693	-10,475	-9.6%	$130.09	98,981	07 Mar 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).
F2	Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.